Paper · 42938348
Long Non-Coding RNA LINC01614 Promotes Aggressive Phenotypes and Ferroptosis Resistance in Papillary Thyroid Cancer Through a Putative miR-4521/IGF2/PI3K-AKT Signaling Axis.
Quaranto D and 9 others. Genes (Basel), 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Long Non-Coding RNA LINC01614 Promotes Aggressive Phenotypes and Ferroptosis Resistance in Papillary Thyroid Cancer Through a Putative miR-4521/IGF2/PI3K-AKT Signaling Axis. Papers, record 42938348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42938348
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long Non-Coding RNA LINC01614 Promotes Aggressive Phenotypes and Ferroptosis Resistance in Papillary Thyroid Cancer Through a Putative miR-4521/IGF2/PI3K-AKT Signaling Axis.
- Journal
- Genes (Basel)
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-28
Source PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferroptosis | Major topic |
| Thyroid Cancer, Papillary | Major topic |
| RNA, Long Noncoding | Major topic |
| Thyroid Neoplasms | Major topic |
| MicroRNAs | Major topic |
| Humans | |
| Proto-Oncogene Proteins c-akt | |
| Signal Transduction | |
| Cell Line, Tumor | |
| Gene Expression Regulation, Neoplastic | |
| Phosphatidylinositol 3-Kinases | |
| Cell Proliferation | |
| Insulin-Like Growth Factor II | |
| Cell Movement | |
| Phenotype |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 130380 | New York State Department of Health | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25,417,114 | Integrated genomic characterization of papillary thyroid carcinoma. | Cell | 2014 | https://conductscience.org/library/papers/25417114 | PubMed |
| 2 | 33,407,516 | Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1. | Mol Cancer | 2021 | https://conductscience.org/library/papers/33407516 | PubMed |
| 3 | 23,429,735 | Molecular pathogenesis and mechanisms of thyroid cancer. | Nat Rev Cancer | 2013 | https://conductscience.org/library/papers/23429735 | PubMed |
| 4 | 38,562,143 | Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/38562143 | PubMed |
| 5 | 24,439,385 | Regulation of ferroptotic cancer cell death by GPX4. | Cell | 2014 | https://conductscience.org/library/papers/24439385 | PubMed |
| 6 | 36,944,609 | The interaction between ferroptosis and inflammatory signaling pathways. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/36944609 | PubMed |
| 7 | 33,000,412 | Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. | Protein Cell | 2021 | https://conductscience.org/library/papers/33000412 | PubMed |
| 8 | 33,353,982 | Gene regulation by long non-coding RNAs and its biological functions. | Nat Rev Mol Cell Biol | 2021 | https://conductscience.org/library/papers/33353982 | PubMed |
| 9 | 33,495,651 | Ferroptosis: mechanisms, biology and role in disease. | Nat Rev Mol Cell Biol | 2021 | https://conductscience.org/library/papers/33495651 | PubMed |
| 10 | 10,405,160 | Ratio-fluorescence microscopy of lipid oxidation in living cells using C11-BODIPY(581/591). | FEBS Lett | 1999 | https://conductscience.org/library/papers/10405160 | PubMed |
1 to 10 of 23
See all 23 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42938348
GET https://conductscience.org/api/papers/v1/42938348/references?page=2